title: The ability of estradiol to induce Fos expression in a subset of estrogen receptor-alpha-containing neurons in the preoptic area of the ewe depends on reproductive status.
abstract: In the ewe, seasonal anestrus results from a change in the hypothalamic responsiveness to estradiol (E2) negative feedback. Considerable evidence has implicated a specific group of dopaminergic neurons (the A15 group) in this seasonally dependent E2 effect, but these neurons do not appear to contain estrogen receptor-alpha (ERalpha). This apparent discrepancy raises the possibility that at least one other neural system is also involved in mediating E2 inhibition. The purpose of this study was to determine whether ERalpha-containing neurons are activated by the negative feedback action of E2 in anestrus. In Exp 1, we examined the effects of E2 on expression of the immediate early gene products, Fos and Fos-related antigens, in ERalpha-positive cells in anestrous ewes. ERalpha and Fos/Fos-related antigens were colocalized using a dual immunofluorescence procedure in sections throughout the hypothalamus from ovariectomized and E2-treated ovariectomized anestrous ewes. A low dose E2 treatment that inhibited LH pulse frequency and induced Fos in A15 dopaminergic neurons in a previous study significantly increased the percentage of ERalpha-containing neurons expressing Fos (17.8% vs. 1.7%) in the medial preoptic area, but not in other hypothalamic areas. In Exp 2, we determined whether there was a seasonal difference in the effect of E2 on Fos/ERalpha colocalization in this region. E2 treatment produced a 3-fold increase in the percentage of ERalpha-positive cells expressing Fos (15.1% vs. 3.4%) in anestrus, but failed to increase ERalpha/Fos colocalization (1.8% vs. 3.5%) during the breeding season. These data raise the possibility that a subset of ERalpha-containing neurons in the medial preoptic area plays a role in the seasonal change in response to E2 negative feedback in the ewe.
authors.affiliation: Department of Physiology, West Virginia University Health Sciences Center, Morgantown 26506-9229, USA.
authors.forename: I
authors.initials: I
authors.lastname: Stefanovic
authors.forename: B
authors.initials: B
authors.lastname: Adrian
authors.forename: H T
authors.initials: HT
authors.lastname: Jansen
authors.forename: M N
authors.initials: MN
authors.lastname: Lehman
authors.forename: R L
authors.initials: RL
authors.lastname: Goodman
mesh_terms: D000780:Anestrus / Q000502:physiology*; D000818:Animals; D002452:Cell Count; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D005786:Gene Expression Regulation / Q000187:drug effects*; D016762:Genes, fos / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D011301:Preoptic Area / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D011863:Radioimmunoassay; D011960:Receptors, Estrogen / Q000096:biosynthesis* / Q000235:genetics; D012621:Seasons; D012756:Sheep; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism
chemical_list: D011960:Receptors, Estrogen; D004958:Estradiol; D007986:Luteinizing Hormone; D014446:Tyrosine 3-Monooxygenase